Pharmacotherapy Update: 2025

All sessions are listed in Central Time (CT). 

Symposia

  • Date:
  • Time: -
  • Track: Education
  • CME/CE: 1.0
  • Options: Also available on-demand

Sponsored by the Pharmacists Section

Moderator: Tasha Woodall, PharmD, BCGP, CPP

The purpose of this symposium is to educate the audience and summarize the changes over the past year in pharmacotherapy. In addition, the symposium will cover clinical implications of cannabis use in older adults, covering a review of evidence and patient-specific considerations. Learning Objectives: (1) communicate the indication for use, mechanism of action, pharmacokinetics, dosing, safety, and drug interactions for newly approved medications; (2) compare potential advantages and disadvantages of incorporating new medications into clinical practice; (3) explain the clinical implications of cannabis use in older adults; (4) implement best practices for initiating cannabis therapy, including patient education, dosing strategies, and follow-up care.         

Newly Approved Medications and Place in Therapy for Older Adults
Megan Carr, PharmD
Clinical Pearls of Cannabis in Older Adults                      
Danielle Fixen, PharmD, BCGP